CLINICAL_TRIALS
trial_result
· 2020-09-04
Clinical Trial Update: Maintenance Lenalidomide in Lymphoma [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating maintenance lenalidomide in lymphoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-09-04